CoChat

Apolipoprotein E genotypes in a neuropathological series from the consortium to establish a registry for Alzheimer's disease

Welsh‐Bohmer, Kathleen A., Gearing, Marla, Saunders, Ann M., Roses, Allen D., Mirra, Suzanne · 1997 · Annals of Neurology

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

We evaluated the sensitivity, specificity, and predictive value of the apolipoprotein E (ApoE) ε4 allele for the neuropathological diagnosis of Alzheimer disease (AD) in a clinical series of well‐characterized AD patients and controls followed longitudinally in the multicenter study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). In the 162 patients for whom autopsy and ApoE genotype data were available, the clinical diagnosis of AD was verified as the primary cause of dementia in 139 cases (139 of 162, or 86%). The sensitivity and specificity of the ε4 allele for AD were both 83%. The positive predictive value of the ε4 allele was very high at 97% (115 of 119); whereas, the negative predictive value was 44% (19 of 43), providing no useful information for diagnosis of AD when the ε4 allele is not present. Of the cases where AD was not considered the primary or sole cause of dementia (n = 23), 6 cases exhibited concomitant neuropathological findings of definite or probable AD and 2 of these 6 cases had at least one ε4 allele. These multicenter data extend previous obsevations reported from smaller case series of single laboratories and demonstrate that once the clinical diagnosis of AD is established, the presence of an ε4 allele reliably predicts the ultimate CERAD neuropathological diagnosis of AD. The findings also suggest that ApoE genotype information is useful clinically in bolstering diagnostic confidence when an ε4 allele is present and in identifying a group of patients for whom additional diagnostic evaluations may be warranted when the 4 allele is absent.

Overview

Integrity signals

Registry

Crossref · 10.1002/ana.410420308

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Welsh KA, 1996, Neuropsychological and neuropathological differentiation of Alzheimer's disease from other dementias: the CERAD experience, J Int Neuropsychol Soc, 2, 12

Cited by

See all 71

Metadata

Authors
Welsh‐Bohmer, K. A., Gearing, M., Saunders, A. M., Roses, A. D., & Mirra, S.
Affiliations
  • Emory University (US)
  • Duke Medical Center (US)
Venue
Annals of Neurology
Publisher
Wiley
Published
1997-09
Volume
42
Issue
3
Pages
319-325
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2024631916
Cited by
67
References
38
Citations by year
2025: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 3 · 2013: 1 · 2012: 2
FWCI
6.91
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ag009997-05)
  • National Institute on Aging (P30AG010130, AG-10130, AG05 128, AG09997, P50AG005128)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
apolipoprotein E, APOE ε4, Alzheimer's disease, neuropathological diagnosis, sensitivity and specificity, predictive value, autopsy, dementia, genetic biomarkers
MeSH terms
Aged, Alleles, Alzheimer Disease, Apolipoproteins E, Female, Follow-Up Studies, Genotype, Humans, Longitudinal Studies, Male, Predictive Value of Tests, Registries, Sensitivity and Specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apolipoprotein E genotypes in a neuropathological series from the consortium to establish a registry for Alzheimer's disease. https://app.cochat.ai/papers/10.1002/ana.410420308
The paper
Welsh‐Bohmer, K. A., Gearing, M., Saunders, A. M., Roses, A. D., & Mirra, S. (1997). Apolipoprotein E genotypes in a neuropathological series from the consortium to establish a registry for Alzheimer's disease. Annals of Neurology. https://doi.org/10.1002/ana.410420308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.